| Catalog | name | Description | price |
|---|---|---|---|
| R-C-2712 | WZ4002 CAS:1213269-23-8 | WZ4002 is a mutant selective EGFR inhibitor with IC50s of 2,8,3 and 2nM for EGFRL858R,EGFRL858R/T790M,EGFRE746-A750 and EGFRE746-A750/T790M,respectively. | price> |
| R-C-2713 | WZ8040 CAS:1214265-57-2 | WZ8040 is an irreversible mutated EGFR T790M inhibitor and inhibits EGFR phosphorylation.WZ8040 displays 100-fold greater activity against the mutated EGFR than the normal. | price> |
| R-C-2717 | OSI-420 CAS:183320-51-6 | OSI-420(Desmethyl Erlotinib,CP-473420)is an orally active EGFR tyrosin kinase inhibitor,which inhibits receptor tyrosine kinases(TKs)by inhibition of the intercellular domain . | price> |
| R-C-2718 | Butein CAS:487-52-5 | Butein is a cAMP-specific PDE inhibitor with an IC50 of 10.4μM for PDE4. Butein is a specific protein tyrosine kinase inhibitor with IC50s of 16 and 65 μM for EGFR and p60c-src in HepG2 cells.Butein sensitizes HeLa cells to Cisplatin through AKT and ERK/p38 MAPK pathways by targeting FoxO3a.Butein is a SIRT1 activator(STAC). | price> |
| R-C-2722 | CP-724714 CAS:537705-08-1 | CP-724714 is a potent,selective and orally active ErbB2(HER2)tyrosine kinase inhibitor,with an IC50 of 10nM.CP-724714 displays a marked selectivity against EGFR kinase(IC50=6400nM).CP-724714 potently inhibits ErbB2 receptor autophosphorylation in intact cells.Antitumor activities. | price> |
| R-C-3076 | SU 5205 CAS:3476-86-6 | SU5205 is an inhibitor of VEGF receptor 2 (VEGFR2/FLK-1) with IC50 of 9.6 µM.Only for scientific research, not for human body. | price> |
| R-C-3077 | SU-5408 CAS:15966-93-5 | SU5408 (VEGFR2 Kinase Inhibitor I) is a potent and selective inhibitor of VEGFR2 Kinase with IC50 of 70 nM.Only for scientific research, not for human body. | price> |
| R-C-3078 | SU 5214 CAS:186611-04-1 | SU5214 is a inhibitor of VEGF receptor 2 (VEGFR2/FLK-1) with IC50 of 14.8 µM and EGFR with IC50 of 36.7 µm, respectively.Only for scientific research, not for human body. | price> |
| R-C-3079 | Ranibizumab cas:347396-82-1 | Ranibizumab is a monoclonal antibody that inhibits angiogenesis by inhibiting Vascular endothelial growth factor A.Only for scientific research, not for human body. | price> |
| R-C-3080 | ACC-789(NVP-ACC789) | ACC-789, also known as NVP-ACC789 and ZK-202650, is a potent, selective and orally active inhibitor of the VEGF receptor tyrosine kinases with potential anticancer activity.Only for scientific research, not for human body. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


